About POS Biosciences
POS Biosciences is a Consumer company based in Saskatoon (Canada) founded in 1973, and was acquired by Bioriginal in February 2024. Plant-based protein products are produced by KeyLeaf in Canada. It operates on a Professional Services and Managed Services model. POS Biosciences offers products and services including Extraction, Oil Processing, Ingredient Development, and Research and Development. Its focus areas include Biotechnology, Food Science and Ingredient Processing. Its legal entity is POS Biosciences Corp.
Company details
POS Biosciences is involved in proprietary processing, extraction, fractionation, isolation, and purification of plant compounds and molecules. The company also focuses on refining and purifying marine oils while collaborating with clients on waste stream valorization. Services include bench top, miniscale, and pre-production scale-up testing and validation, as well as early-stage contract manufacturing. Support is provided for concept-to-commercialization processes across food science and biotechnology sectors, with an emphasis on optimizing product quality and utilizing waste streams for profitability.
- Headquarters Saskatoon, Canada
- Stage Acquired
- SectorsConsumer
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website keyleaf.ca
- Social LinkedIn X Facebook
- Acquired by Canopy Growth (Jun 2019)
- Legal Name Pos Biosciences Corp.
- InvestorsCanopy Growth
& 2 more
- Acquired by
Products & Services of POS Biosciences
POS Biosciences offers a comprehensive portfolio of products and services, including Extraction, Oil Processing, Ingredient Development, and Research and Development.
Extraction of plant compounds is performed for clients.
Marine oils are refined and purified for clients.
Ingredients are developed for commercialization by the team.
Research services are provided for product scale-up testing.
Funding Insights of POS Biosciences
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of POS Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2017 | Unspecified | β | Avrio Sub Debt | β |
3 investors in total: 3 institutional.
Investors in POS Biosciences
POS Biosciences has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Canopy Growth, Bioriginal and Avrio Sub Debt.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Flexible subordinated debt financing is offered for food and agriculture companies. | 2002 | avriosubdebt.com | Calgary, Canada | |
Cannabis products are provided to support consumer wellness and health. | 2013 | canopygrowth.com | Smiths Falls, Canada | |
Brand of protein supplements | 1993 | bioriginal.com | Saskatoon, Canada |
Investor details for POS Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of POS Biosciences
18 people are tracked at POS Biosciences (2 in leadership, 16 in team).
| Name | Role | Group |
|---|---|---|
Mike Galbraith | General Manager | Leadership |
Justin White | Vice President, Global Sales & Business Development | Leadership |
Scott Laking | Plant Manager | Team |
Andria Laughren | QA & Regulatory Affairs Manager | Team |
Christopher Stefan | Quality Control Manager | Team |
Subhani Pathiratne | Analytical Laboratory Manager | Team |
Shahram Emami | Scientist | Team |
Darlene Williams | Senior Technician | Team |
Herve Douce | Manager of Engineering Services | Team |
Joseph Hayes | Process Operator III | Team |
Grace Zhao | Lab Technician II | Team |
Romil Songara | Process Operator L | Team |
Candice B | Executive Assistant | Team |
Dipkumar Patel | IT Specialist | Team |
Lori Cherkowski | Maintenance Coordinator | Team |
Kevin Mack | Process Operator | Team |
Warren Schwab | Laboratory Technologist III | Team |
Manuel E. Torres | Process Operator I | Team |
Complete people profiles for POS Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of POS Biosciences
4 dated milestones of POS Biosciences across 51 years, from founding to its latest funding, stage changes and deals.
- Founded POS Biosciences is founded.
- Funding First funding round.
- Exit Acquired by Canopy Growth.
- Exit Acquired by Bioriginal.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about POS Biosciences
POS Biosciences was founded in 1973 and raised its 1st funding round 44 years after it was founded.
POS Biosciences is headquartered in Saskatoon, Canada. It is registered at Saskatoon, Saskatchewan, Canada.
POS Biosciences is involved in proprietary processing, extraction, fractionation, isolation, and purification of plant compounds and molecules. The company also focuses on refining and purifying marine oils while collaborating with clients on waste stream valorization. Services include bench top, miniscale, and pre-production scale-up testing and validation, as well as early-stage contract manufacturing. Support is provided for concept-to-commercialization processes across food science and biotechnology sectors, with an emphasis on optimizing product quality and utilizing waste streams for profitability.
POS Biosciences offers Extraction, Oil Processing, Ingredient Development, and Research and Development.
POS Biosciences has 3 investors. Key investors include Canopy Growth, Bioriginal, and Avrio Sub Debt.
POS Biosciences operates through Pos Biosciences Corp..
Yes. POS Biosciences was acquired by Canopy Growth in June 2019.
